Cancer Chemotherapy and Biological Response Modifiers, Annual 16 (16) - Couverture rigide

 
9780444823267: Cancer Chemotherapy and Biological Response Modifiers, Annual 16 (16)

Synopsis

Offering developments in pharmacology of anti-cancer agents, the area of biologicals and clinical management of the cancer patient, this study discusses the introduction of taxol, taxotere, gemcitabine, the topo 1 inhibitor, CTp-11 and TS such as tomudex.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.